Allogene Therapeutics, Inc. · NASDAQ:ALLO
Pfizer Inc reported a 9.00% stake in Allogene Therapeutics, Inc. (Schedule 13D/A)
Event Nov 6, 2025 · Filed Feb 13, 2026
Pfizer Inc reported a 9.00% stake in Allogene Therapeutics, Inc., 22,032,040 shares, with active intent on Nov 6, 2025. Filed Feb 13, 2026 (Schedule 13D/A).
- Stake
- 9.00%
- Shares
- 22,032,040
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Pfizer Inc. | 9.00% | 22,032,040 |
Source
Related
- Allogene Therapeutics, Inc.
- Pfizer Inc
- Allogene Therapeutics, Inc. shareholders
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026